ImmunoScape enables the characterization of a patient’s immune profile at unprecedented resolution. Our assays provide a view into the immune system in action, directly observing T cell phenotype & function with simultaneous tracking of TCR-antigen binding.
Our platform delivers key insights on antigen-specific T cells in studies of immune checkpoint blockade, therapeutic and prophylactic vaccines, and T cell therapy, empowering researchers and drug developers.
Discover novel vaccine, antibody, or cell therapy targets
Evaluate treatment outcomes through longitudinal studies
Design successful clinical trials through efficient patient enrollment
Uncover combinations of predictive biomarkers of disease or treatment efficacy
Demonstrate proof-of-mechanism in tissues of interest
To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.
Location: Singapore
Employees: 11-50
Total raised: $49M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Anzu Partn... | anzupartne... |
| - | The Univer... | ut-ec.co.j... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 20.09.2022 | - | $24M | - |
| 06.05.2021 | - | $14M | - |
| 12.08.2020 | - | $11M | Anzu Partn... |
Mentions in press and media 13
| Date | Title | Description | Source |
| 20.09.2022 | ImmunoScape Finds $24M From Amgen, Others | San Diego-based ImmunoScape, a biotech company which says it is focused on discovery and development... | socaltech.... |
| 20.09.2022 | ImmunoScape Raises $14M in Funding | ImmunoScape, a San Diego, CA and Singapore-based pre-clinical biotechnology company, raised $14M in ... | finsmes.co... |
| 20.09.2022 | ImmunoScape Raises $14M to Facilitate the Discovery and Char... | We use cookies on our website to give you the most relevant experience by remembering your preferenc... | anzupartne... |
| 29.04.2021 | ImmunoScape Raises $14 Million | ImmunoScape, a biotech company which specializes in cancer treatment, has raised $14 million fundrai... | sdbj.com/n... |
| 14.04.2021 | ImmunoScape Raises $14M To Advance Deep Immunomics Platform ... | We use cookies on our website to give you the most relevant experience by remembering your preferenc... | anzupartne... |
| 14.04.2021 | ImmunoScape has raised a $14M funding round to further expan... | - | connect.or... |
| 14.04.2021 | ImmunoScape Raises $14M in Funding | ImmunoScape, a Singapore and San Diego, CA-based biotech company with an immunomics-based technology... | finsmes.co... |
| 14.04.2021 | ImmunoScape : Raises $14M To Advance Deep Immunomics Platfor... | ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insi... | marketscre... |
| 12.08.2020 | ImmunoScape Raises $11M in Financing | ImmunoScape, a Singapore-based biotech firm enabling insights into the human immune system, raised U... | finsmes.co... |
| 11.08.2020 | ImmunoScape Targets Immunology Breakthroughs for COVID-19 an... | We use cookies on our website to give you the most relevant experience by remembering your preferenc... | anzupartne... |
Show more